How Elacestrant Targets ESR1 Mutations
Addressing the critical role of ESR1 mutations in hormone receptor-positive breast cancer, new treatments like Elacestrant provide hope against resistance to standard therapies. By exploring innovative therapies and detection methods, healthcare providers can enhance patient outcomes in metastatic cases. Delve into the promising advancements and ongoing research efforts shaping future strategies. Understanding ESR1 Inhibitors in […]
3 minute read